Ebola Virus News and Research

RSS
Ebola, also known as Ebola hemorrhagic fever or Ebola viral disease, is a rare and deadly illness caused by one of the strains of Ebola virus. This viral agent is regarded as a prototype pathogen of viral hemorrhagic fever, with high fatality rates in humans and primates. The natural reservoir of Ebola virus remains unknown, although bats seem to be the most likely reservoir.
Experimental therapies offer patients a greater chance of surviving Ebola virus disease

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

First Ebola vaccine prequalified by WHO for use in high-risk countries

First Ebola vaccine prequalified by WHO for use in high-risk countries

New approach may help kill Mycobacterium tuberculosis

New approach may help kill Mycobacterium tuberculosis

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Risk assessment model for Ebola transmission accurately predicted Uganda cases

Risk assessment model for Ebola transmission accurately predicted Uganda cases

Tightening of Ebola care practice rules following survivor’s death

Tightening of Ebola care practice rules following survivor’s death

Ebola virus vaccine still effective against the infection even in low concentrations

Ebola virus vaccine still effective against the infection even in low concentrations

Highly diluted candidate Ebola vaccine remains fully protective against disease in macaques

Highly diluted candidate Ebola vaccine remains fully protective against disease in macaques

Computer model predicts location of future Ebola virus outbreaks

Computer model predicts location of future Ebola virus outbreaks

Scientists show how the immune system reacts to Ebola vaccine

Scientists show how the immune system reacts to Ebola vaccine

Scientists uncover details of antibody response to Ebola virus vaccine

Scientists uncover details of antibody response to Ebola virus vaccine

Texas Biomed scientists continue testing therapies and vaccines for Ebola virus

Texas Biomed scientists continue testing therapies and vaccines for Ebola virus

Second round of Ebola vaccination trials on the way to DRC

Second round of Ebola vaccination trials on the way to DRC

Tanzania keeping Ebola under wraps

Tanzania keeping Ebola under wraps

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

2019 ASTMH Annual Meeting to focus on Ebola, monkey malaria, and other infectious diseases

UMSOM receives landmark contract from NIAID for influenza research

UMSOM receives landmark contract from NIAID for influenza research

Mutant live attenuated Ebola virus elicits protective immunity in monkeys

Mutant live attenuated Ebola virus elicits protective immunity in monkeys

Scientists join hands to protect Australia from growing threat of infectious diseases

Scientists join hands to protect Australia from growing threat of infectious diseases

Community-based wildlife mortality surveillance program could help prevent Ebola outbreaks

Community-based wildlife mortality surveillance program could help prevent Ebola outbreaks

Harnessing power of CRISPR to control behavior of DNA-responsive materials

Harnessing power of CRISPR to control behavior of DNA-responsive materials